The need for scalable and high-throughput approaches to screening using 3D human stem cell models remains a central challenge in using stem cell disease models for drug discovery. It is imperative to develop standardized systems for phenotypic screening, yet most researchers screen cells across different platforms using a multitude of assays. In this study, we have developed a workflow centered on a small array of assays that can be employed to screen 3D stem cell cultures across a set of platforms. This workflow can be used as a starting point for a standardized approach to phenotypic screening. In this manuscript we hope to provide a roadmap for groups looking to start high-content screening using 3D organoid systems. To do this, we employ serum-free embryoid bodies (SFEBs) created from human induced pluripotent stem cells (hiPSCs). SFEBs are used in this study because they do not display the same level of heterogeneity observed in other neural organoid systems and they are amenable to high content imaging without cryosectioning. They contain populations of excitatory and inhibitory neurons that form synaptically active networks 1 and medium-to high-throughput electrophysiology can be performed using SFEBs via the multielectrode array (MEA). The assays outlined in this study allow SFEBs to be scanned for neurite outgrowth, cell number and electrophysiological activity.
Introduction
Three-dimensional (3D) cell culture models derived from hiPSCs provide a promising avenue for studying disease mechanisms and for drug discovery because they can potentially recapitulate aspects of in vivo physiology more accurately than 2D systems. Previous studies have shown that 3D and 2D cultures vary greatly in terms of cell proliferation, differentiation, migration, cytoarchitecture, oxygen and nutrient gradients, and cell-cell and cell-extracellular matrix interactions 2, 3 . These altered conditions impact cellular phenotypes and drug responses, and could ultimately lead to high failure rates in early stages of phenotypic drug screens performed solely in 2D cultures 4 .
More recently, the use of hiPSC to generate neural 3D cultures has improved our ability to model neurodevelopmental disorders with complex genetic and environmental etiologies, striking a balance between the relative simplicity of 2D cultures and the limited genetic heterogeneity and immense cost of animal models 5 . Brain organoids self-organize into neuroepithelial structures analogous to early fetal development, and form electrically-active networks. Several protocols have been developed to convey regional identities by the addition of patterning factors. Studies also have shown that neurons in 3D cultures are more electrically robust, and express more genes involved in neurological processes [5] [6] [7] . Many different methods for generating 3D cultures have emerged, including spheroid cultures, spinning bioreactors, microfluidic systems, and biopolymer scaffolds 2 . However, the utility of these culture methods, particularly in drug screening pipelines, has been hampered by a high degree of experimental and biological heterogeneity, increased cost, and the lack of validated methodologies for quantitative analysis 8, 9 . 3D systems that model the development of cortical networks are typically difficult to work with in imaging and electrophysiological applications at scale because the tissue thickness requires cryosectioning and other special handling 7 . The development and adoption of mediumto high-throughput strategies for assaying 3D culture models is paramount to overcoming these challenges.
A technique developed by Nestor et al 1 creates 3D SFEBs that approximate cortical development while also facilitating imaging and electrophysiological recording without the need for further processing. By transferring SFEBs onto cell-culture inserts composed of the polytetrafluoroethylene (PTFE) after aggregation, SFEBs thin to ~100 µm allowing highthroughput imaging in multi-well plates while maintaining synaptic connections 1 . SFEBs contain a heterogeneous population of calretinin-and calbindin-positive interneurons, vesicular glutamate transporter (VGlut) positive excitatory neurons and Tbr1-positive glutamatergic neural progenitors, and astrocytes, and can be used to model early cortical networks 1, 10, 11 . SFEBs also provide a consistent platform for working with 3D systems because they are less variable than other cerebral organoids 11 . The SFEBs used in this method are derived from peripheral blood mononuclear cells (PBMCs) and retain the original genetics and disease susceptibility of the individual from which they were derived; thus they are an excellent resource for in vitro disease modelling 12 . SFEBs derived from hiPSCs from control and disease cohorts can be used in combination with high-throughput screening assays to generate sufficient statistical power to compensate for the high variability observed in cerebral organoid systems 8 .
Here we developed a framework and protocol to take advantage of the benefits of 3D systems, while compensating for their deficiencies. High-content imaging was utilized to analyze SFEBs for neurite outgrowth and morphology, cell population, and multiple other parameters. As SFEBs are electrophysiologically active, electrophysiological measurements were obtained in parallel via MEA to measure spontaneous and evoked spiking as well as long-term potentiation to model cortical network aberrations. In addition, Ca 2+ imaging can be used as an analogue for single-cell action potentials 13 . These measurements can be taken before and after pharmacological manipulation allowing for the assaying of drug effects and to examine receptor function and synaptic plasticity. We describe a novel workflow to allow interrogation of SFEBs using three multiplex high-throughput techniques, namely immunohistochemistry, multielectrode array (MEA) for electrophysiology, and Ca 2+ imaging, on ArrayScan high-throughput technology (Figure 1 ).
Materials and Methods

Generation of SFEBs from hiPSCs
The hiPSCs were derived from PBMCs and maintained on a gamma-irradiated mouse embryonic with PBS and incubated with blocking solution (PBS with 5% Normal Donkey Serum (Jackson Immunoresearch Labs) and 0.1% Triton-X) for one hour. After blocking solution was removed, SFEBs were incubated with rabbit anti-VGlut primary antibody (1:250, Synaptic Systems) in blocking solution overnight at 4°C, then washed 3x with PBS with 0.1% Triton-X. This was followed by secondary antibody incubation (Donkey anti-Rabbit Secondary Antibody, Alexa
Fluor 594, 1:1000, ThermoFisher) for one hour at room temperature, after which SFEBs were washed 3x with PBS with 0.1% Triton-X. SFEBs were incubated with 0.1 µg/ml Hoechst 33342 for 10 minutes at room temperature and washed once with PBS with 0.05% sodium azide. Prior to imaging, the plates were centrifuged at 163xg for 3 minutes and excess PBS was removed to facilitate auto-focusing.
ArrayScan XTI High Content Analysis Reader and the HCS Studio Cell Analysis
Software (ThermoFisher Scientific) was used for high-content imaging analysis. This system is an automated image acquisition platform designed for confocal fluorescence imaging in microplates and is able to perform quantitative morphological measurements on a cell-by-cell or field-by-field basis. Due to the challenges of imaging SFEBs in suspension, and to account for variable thickness and size of SFEBs, microplate form factors were calibrated using average Zfocus obtained from several wells. Autofocusing was performed for each well using Hoechst 33342, with relaxed parameters and extended range of focus with 4x4 binning. Once autofocus was optimized, exposure times were calculated for each channel by setting the target percentile between 8-10%. Z-stacks were obtained for each channel in order to capture the entire range of the SFEB, and maximum intensity Z-projection was performed.
To analyze images, the neurite detection protocol was used on HCS studio. This protocol 
Statistics
Statistical analyses were performed using SigmaPlot 13.0 (Systat Software, Inc.). Normality was tested for all data-sets using the Shapiro-Wilk Test. For high-content imaging data, control and patient data were compared using the Mann-Whitney Rank Test. For electrophysiology, activity before and after drug administration was tested using the paired Wilcoxon-Signed Rank Test. All graphs were generated using Prism 6.0 (GraphPad Software Inc.)
Results and Discussion
The SFEBs used in our system were generated from either control or patient cohorts. Upon maturing, SFEBs can be transferred to either a 48-well MEA plate allowing MEA recordings, single cell Ca 2+ imaging, and immunocytochemistry, or a 96-well glass bottom plate for morphological studies. These SFEBs have telencephalon/forebrain characteristics and active glutamate/GABA synapses 10 . Neuronal markers showed that cells grow in an 'inside out' motif, similar to the development of the cortical subventricular zone 1 . High-throughput experimental techniques increase statistical power in this system and allow for detection and quantification of small differences between groups.
Neuronal morphology
In order to quantify morphological changes between control and disease SFEBs, we performed high content screening using the ArrayScan XTI in SFEBs stained with the excitatory neuron marker VGlut with Hoechst as a nuclear stain. This method allows the detection of changes even
in the presence of variability within each line. After scanning 96-well plates, images can be assayed at the level of individual wells, microscope field, or individual cells (Figure 2a,b) .
Masking protocols were used to measure multiple properties of VGlut positive (VGlut+) cells in control vs. disease cohorts. Total nuclei within the SFEB were decreased by 68%, (Figure 2c ) in disease when compared to control, indicating that there were fewer cells per SFEB. When limiting measurements to excitatory neurons (VGlut+), the decrease was limited to 27% ( Figure   2d ). Additionally, the surface area of VGlut+ cells was also decreased by 50% (Figure 2e ). In contrast, the disease model showed a 40% increase in VGlut+ neurite length (Figure 2d) , with no significant difference in the number of branch points (Figure 2f ). We observed a high degree of variability within SFEBs from the same line, and thus statistically significant changes may not be apparent using a lower sample size. Additionally, the method allows for analysis of several morphometric characteristics in a time-and cost-effective manner.
A major limitation of imaging 3D cultures is that high cellular density and high refractive index of components within the cell membrane results in the scattering of light 16, 17 . In the past, this has led to high-throughput screening techniques resulting in incomplete data sets and false negative data points 18 . Light scattering typically restricts imaging to the outer layers and restricts the use of more advanced physiological techniques such as microphotolysis and optogenetics.
This method of growing the SFEBs in PTFE cell-culture inserts causes significant thinning compared to other 3D culture models 1 , allowing for greater penetration of light and limiting refraction. This allows for adoption of high content imaging techniques without the need for more labor-intensive processing such as sectioning, which is currently required in studying most 3D models 19 . Chemical clearing reagents can also be introduced in conjunction with this method to improve imaging by eliminating artifacts and high background fluorescence, although the effectiveness would need to be tested for individual markers. Tissue clearing protocols can also aid antibody penetration, which in turn allows for increased resolution of SFEB morphology.
Network Firing Rates
SFEB local field potentials can be measured by MEA plates for multiple different endpoints. The most obvious are inherent differences in spontaneous activity between different groups, but bursting and network activity also can be examined. These measurements can be taken in the context of pharmacological manipulation of SFEB excitatory and inhibitory connections or modulatory neurotransmitter receptors. In this study, we used the NMDA antagonist APV (Figure 3a) . Application of the GABA antagonist picrotoxin (PTX, 50µM) increased the mean firing rate and burst frequency of control and disease SFEBs ( Figure   3b ). This shows significant excitatory and inhibitory neurotransmission in this culture model, consistent with previous findings indicating the presence of significant populations of excitatory and inhibitory neurons 10, 11 . Synaptic plasticity, particularly long-term potentiation (LTP), also can be tested using this method. Addition of glycine has been shown to induce NMDAdependent chemical LTP in cultured neurons 20 . Upon addition of glycine, we observed a significant increase in firing rate and burst frequency, which might be consistent with LTP induction (Figure 3c ).
Neuronal activity and local field potentials are largely dictated by local microcircuitry.
To this end, we utilized our high content screening platform to analyze excitatory neuron populations surrounding individual electrodes. Using masking protocols, we were able to delineate an area of ~100 µm surrounding electrodes on a 48 well-MEA and quantify the percentage of VGlut+ cells surrounding active electrodes (at least 5 spikes per minute).
Interestingly, although exhibiting higher spontaneous firing, disease SFEBs have less VGlut+ cells surrounding active electrodes compared to controls (Figure 3d ). This may suggest altered inhibitory neuron populations or activity, or may indicate changes in the maturation state of excitatory neurons, which could point to interesting mechanisms underlying a disease phenotype.
Calcium Signaling
Field recordings obtained by MEA can be supplemented by single-cell calcium imaging, which can provide information about the activity and location of individual neurons. For this method, we utilized the genetically encoded fluorescent calcium sensor GCaMP6s 13 to visualize neural activity. Calcium transients were visible in SFEBs 7 days after induction with virus. High content imaging and analysis were performed using the ArrayScan XTI which allowed masking of individual cells and recording of average fluorescence over multiple time points ( Figure 4A ).
To confirm that this activity originated from individual cells, individual electrodes were imaged at 20x. At this magnification, individual cells were clearly observed ( Figure 4C ). Analysis of high content fluorescence data using PeakCaller yielded the total number of fluorescent peaks, as well as the correlation of neuronal activity over time.
Alternatively, single-cell activity can be studied via spike sorting, allowing spikes from putative neurons to be extracted from field recordings. This allows for a detailed examination of changes in spike properties from individual neurons such as amplitude, width, and spike-timing dependent plasticity.
Conclusion
This workflow can be used to integrate high-throughput multiplex assays, heterogeneous patient population samples, and 3D culture to generate a vast amount of morphological and electrophysiological data that is more likely to reflect in vivo physiology 19 compared to 2D cultures. SFEBs mimic early cortical development, and these assays may lead to a more complete understanding of the etiology of neurological disorders that originate developmentally.
Additionally, the use of hiPSCs allows for the investigation of patient-specific pathophysiology.
This approach can also be utilized for identification of potential drug targets and incorporated into a drug discovery pipeline. 3D cultures are more likely to reflect in vivo physiology compared to 2D cultures based on differences in cell proliferation, viability, gene expression profiles, and drug responses, and can potentially reduce development time, costs, and failure rates in drug discovery 19 . Ultimately, this is contingent upon further validation and standardization of techniques, and increased automation which can reduce experiment variability and improve cost-effectiveness. Overall, this method demonstrates the ability to gather rich and consistent quantitative data sets to detect differences between control and disease lines despite high variability inherent in 3D systems. There was a 24% and 57% decrease in burst frequency in control and disease SFEBs, respectively (Control: spontaneous = 0.0503 Hz ± 0.00668; APV CNQX = 0.038Hz ± 0.00612; p = 0.020; Disease: spontaneous = 0.0494 Hz ± 0.00725; APV CNQX = 0.0234Hz ± 0.00425; p < 0.001). Network correlation as measured by frequency of network bursts and synchrony index.
Network burst frequency was decreased by 72% in control lines (spontaneous = 0.00553 Hz ± 0.00153; APV CNQX = 0.00153 Hz ± 0.000489; p = 0.004) and 85% in disease lines frequency by 39% (spontaneous = 0.0205 Hz ± 0.00377; cLTP = 0.0506 Hz ± 0.00452; p = 0.005), network burst frequency by 2.9-fold (spontaneous = 0.00110 Hz ± 0.000738; cLTP = 0.00317 Hz ± 0.00166; p < 0.001), and synchrony index by 66% (spontaneous = 0.00423 ± 0.000744; cLTP = 0.00703 ± 0.00152; p < 0.001). All experiments were done in triplicate (n=128) and statistical analysis was done via the paired Wilcoxon Signed Rank Test. (D) In order to identify active electrodes, MEA recordings were performed and a threshold was set at a minimum of 5 spikes/min. Electrodes that met these criteria were imaged to assay the number of excitatory neurons that stained positive for VGlut within a 100 µm radius. This was done to examine the local microcircuitry surrounding active electrodes. The percentage of VGlut+ cells around active electrodes was lower in disease SFEBs (control = 0.2945 % ± 0.008272, n= 475 electrodes; disease = 0.2208 % ± 0.007208, n = 391 electrodes, p < 0.0001, Mann Whitney U). 
